Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Effect of Octreotide on the Colonic Motility in Pediatric Patients

Phase 4

Completed

Conditions: Colonic Motility Index
Constipation

Interventions: Drug: Octreotide
Drug: Bisacodyl

First Posted Date: 2013-08-07

Last Posted Date: 2015-12-21

Lead Sponsor: Indiana University

Target Recruit Count: 13

Registration Number: NCT01917773

Locations: 🇺🇸
Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,, Indianapolis, Indiana, United States

Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis

Phase 2

Completed

Conditions: Post-ERCP Pancreatitis

Interventions: Drug: high dose indomethacin
Drug: standard dose indomethacin

First Posted Date: 2013-07-31

Last Posted Date: 2019-07-05

Lead Sponsor: Indiana University

Target Recruit Count: 1037

Registration Number: NCT01912716

Locations: 🇺🇸
Aurora St. Lukes' Medical Center, Milwaukee, Wisconsin, United States
🇺🇸
Methodist Dallas Medical Center, Dallas, Texas, United States
🇺🇸
Indiana University Health, Indianapolis, Indiana, United States

and more 3 locations

Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation

Early Phase 1

Completed

Conditions: Liver Transplantation

First Posted Date: 2013-07-26

Last Posted Date: 2014-07-24

Lead Sponsor: Indiana University

Target Recruit Count: 1

Registration Number: NCT01909401

Locations: 🇺🇸
Indiana University School of Medicine - IUHealth-University Hospital, Indianapolis, Indiana, United States

The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia

Phase 2

Terminated

Conditions: Schizophrenia

Interventions: Drug: LY500307 150mg
Drug: Placebo
Drug: LY500307 75mg
Drug: LY500307 25mg

First Posted Date: 2013-06-11

Last Posted Date: 2019-07-02

Lead Sponsor: Indiana University

Target Recruit Count: 95

Registration Number: NCT01874756

Locations: 🇺🇸
Indiana University Center for NeuroImaging, Indianapolis, Indiana, United States
🇺🇸
IU Biostatistics, Indianapolis, Indiana, United States
🇺🇸
Larue D Carter Memorial Hospital, Indianapolis, Indiana, United States

and more 1 locations

Aspiring to Awesome- Patient Preference Privacy Selections in EMR

Completed

Conditions: Sexually Transmitted Diseases

Interventions: Other: Patient preferences

First Posted Date: 2013-05-24

Last Posted Date: 2018-01-19

Lead Sponsor: Indiana University

Target Recruit Count: 136

Registration Number: NCT01862133

Locations: 🇺🇸
Wishard Health Services, Primary Care Center, Indianapolis, Indiana, United States

Meaningful Activity Intervention for Persons With Mild Cognitive Impairment

Phase 1

Completed

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Daily Enhancement Meaningful Activity (DEMA)
Behavioral: Information Support (IS)

First Posted Date: 2013-04-30

Last Posted Date: 2016-10-25

Lead Sponsor: Indiana University

Target Recruit Count: 80

Registration Number: NCT01843283

Locations: 🇺🇸
Indiana University School of Nursing, Indianapolis, Indiana, United States

Encourage Healthy Families

Not Applicable

Completed

Conditions: Pre-diabetes
Gestational Diabetes Mellitus

Interventions: Behavioral: Diabetes Prevention Program (DPP)

First Posted Date: 2013-04-04

Last Posted Date: 2017-08-25

Lead Sponsor: Indiana University

Target Recruit Count: 335

Registration Number: NCT01823367

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States

Small Intestinal Bacterial Overgrowth: a Prospective Registry

Conditions: Functional Dyspepsia
Small Intestinal Bacterial Overgrowth

First Posted Date: 2013-04-02

Last Posted Date: 2025-03-03

Lead Sponsor: Indiana University

Target Recruit Count: 200

Registration Number: NCT01822470

Locations: 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States

Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression

Not Applicable

Recruiting

Conditions: Traumatic Brain Injury

Interventions: Drug: Placebo
Drug: Buspirone

First Posted Date: 2013-04-01

Last Posted Date: 2025-04-18

Lead Sponsor: Indiana University

Target Recruit Count: 74

Registration Number: NCT01821690

Locations: 🇺🇸
Indiana University and Rehabilitation Hospital of Indiana, Indianapolis, Indiana, United States

Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Other: CHICA Type 2 Diabetes Module

First Posted Date: 2013-03-20

Last Posted Date: 2017-05-15

Lead Sponsor: Indiana University

Target Recruit Count: 1369

Registration Number: NCT01814787

Locations: 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy